{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:48:20Z","timestamp":1787676500918,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.htct.2019.02.005","type":"journal-article","created":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T17:18:26Z","timestamp":1560532706000},"page":"292-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Infections in patients with multiple myeloma treated with conventional chemotherapy: a single-center, 10-year experience in Pakistan"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7681-3348","authenticated-orcid":false,"given":"Mohammad Faizan","family":"Zahid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Haider","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Iftikhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Usman","family":"Bin Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arhama","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Atif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Asim","family":"Beg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.htct.2019.02.005_bib0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood.V98.1.23","article-title":"Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients","volume":"98","author":"Kay","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.htct.2019.02.005_bib0170","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2141.1998.00525.x","article-title":"B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors","volume":"100","author":"Rawstron","year":"1998","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.htct.2019.02.005_bib0175","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1182\/blood.V98.10.2992","article-title":"Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-\u03b21 and interleukin-10","volume":"98","author":"Brown","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.htct.2019.02.005_bib0180","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3324\/haematol.2011.054015","article-title":"Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study","volume":"97","author":"Kristinsson","year":"2012","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.htct.2019.02.005_bib0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/j.seminhematol.2009.03.006","article-title":"Infections in patients with multiple myeloma","volume":"46","author":"Nucci","year":"2009","journal-title":"Semin Hematol"},{"issue":"5","key":"10.1016\/j.htct.2019.02.005_bib0190","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3109\/10428194.2011.555027","article-title":"Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide","volume":"52","author":"Offidani","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.htct.2019.02.005_bib0195","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3324\/haematol.2012.075051","article-title":"Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials","volume":"98","author":"Bringhen","year":"2013","journal-title":"Haematologica"},{"issue":"Suppl. 2","key":"10.1016\/j.htct.2019.02.005_bib0200","first-page":"32","article-title":"Infection in multiple myeloma","volume":"31","author":"Nucci","year":"2009","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"8","key":"10.1016\/j.htct.2019.02.005_bib0205","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1080\/10428190500472503","article-title":"Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections","volume":"47","author":"Sch\u00fctt","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.htct.2019.02.005_bib0210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3324\/haematol.2014.107714","article-title":"Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients","volume":"100","author":"Blimark","year":"2015","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.htct.2019.02.005_bib0215","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy381","article-title":"A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology","volume":"67","author":"Miller","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.htct.2019.02.005_bib0220","series-title":"Myeloma","first-page":"223","article-title":"Infections: principles of prevention and therapy","author":"Kelleher","year":"2002"},{"issue":"4","key":"10.1016\/j.htct.2019.02.005_bib0225","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.beha.2005.01.013","article-title":"Renal, hematologic and infectious complications in multiple myeloma","volume":"18","author":"Blad\u00e9","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"issue":"3","key":"10.1016\/j.htct.2019.02.005_bib0230","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4274\/tjh.2013.0173","article-title":"Infections in hospitalised patients with multiple myeloma: main characteristics and risk factors","volume":"32","author":"Valkovi\u0107","year":"2015","journal-title":"Turk J Haematol"},{"issue":"6","key":"10.1016\/j.htct.2019.02.005_bib0235","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.hoc.2007.08.006","article-title":"Complications of multiple myeloma","volume":"21","author":"Blad\u00e9","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"10.1016\/j.htct.2019.02.005_bib0240","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0002-9343(81)90303-X","article-title":"Influence of treatment and response status on infection risk in multiple myeloma","volume":"71","author":"Perri","year":"1981","journal-title":"Am J Med"},{"issue":"17","key":"10.1016\/j.htct.2019.02.005_bib0245","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/archinte.158.17.1889","article-title":"Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution","volume":"158","author":"Blad\u00e9","year":"1998","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.htct.2019.02.005_bib0250","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-96-1-47","article-title":"Biphasic pattern of bacterial infection in multiple myeloma","volume":"96","author":"Savage","year":"1982","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.htct.2019.02.005_bib0255","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/00007611-198807000-00012","article-title":"Multiple myeloma: infectious complications","volume":"81","author":"Doughney","year":"1988","journal-title":"South Med J"},{"issue":"4","key":"10.1016\/j.htct.2019.02.005_bib0260","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1751-553X.2009.01154.x","article-title":"Multiple myeloma presenting with an acute bacterial infection","volume":"31","author":"Kalambokis","year":"2009","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"10.1016\/j.htct.2019.02.005_bib0265","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1751-553X.2007.00930.x","article-title":"Pneumococcal septic arthritis as the initial presentation of multiple myeloma","volume":"30","author":"Sumrall","year":"2008","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"10.1016\/j.htct.2019.02.005_bib0270","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/jcp.48.3.260","article-title":"Immunological factors and risk of infection in plateau phase myeloma","volume":"48","author":"Hargreaves","year":"1995","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.htct.2019.02.005_bib0275","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.hrtlng.2005.10.001","article-title":"Fever of unknown origin (FUO) caused by multiple myeloma: the diagnostic value of the Naprosyn test","volume":"35","author":"Cunha","year":"2006","journal-title":"Heart Lung"},{"issue":"2","key":"10.1016\/j.htct.2019.02.005_bib0280","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000225611","article-title":"Changing patterns of infections in patients with multiple myeloma","volume":"39","author":"Shaikh","year":"1982","journal-title":"Oncology"},{"issue":"4","key":"10.1016\/j.htct.2019.02.005_bib0285","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00001432-200208000-00001","article-title":"Infectious risks and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the picture?","volume":"15","author":"Junghanss","year":"2002","journal-title":"Curr Opin Infect Dis"},{"issue":"36","key":"10.1016\/j.htct.2019.02.005_bib0290","doi-asserted-by":"crossref","first-page":"9219","DOI":"10.1200\/JCO.2005.03.2086","article-title":"Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002 \u2013 Medical Research Council Adult Leukaemia Working Party","volume":"23","author":"Augustson","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.htct.2019.02.005_bib0295","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1600-0609.2012.01814.x","article-title":"Infection complications in an unselected cohort of patients with multiple myeloma treated with lenalidomide combinations","volume":"89","author":"Caravita","year":"2012","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.htct.2019.02.005_bib0300","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0002-9343(95)00043-7","article-title":"Prophylactic antibiotics for the prevention of early infection in multiple myeloma","volume":"100","author":"Oken","year":"1996","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.htct.2019.02.005_bib0305","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1038\/leu.2012.124","article-title":"Oral antibiotic prophylaxis of early infection in multiple myeloma: a URCC\/ECOG randomized phase III study","volume":"26","author":"Vesole","year":"2012","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.htct.2019.02.005_bib0310","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2141.2011.08574.x","article-title":"Guidelines for supportive care in multiple myeloma 2011","volume":"154","author":"Snowden","year":"2011","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.htct.2019.02.005_bib0315","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood-2003-04-1045","article-title":"Treatment of multiple myeloma","volume":"103","author":"Barlogie","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.htct.2019.02.005_bib0320","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-0609.1983.tb01500.x","article-title":"Antibody response to pneumococcal vaccination in patients with myelomatosis","volume":"30","author":"Birgens","year":"1983","journal-title":"Scand J Haematol"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137919300860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137919300860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:31:31Z","timestamp":1762867891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137919300860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S2531137919300860"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2019.02.005","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infections in patients with multiple myeloma treated with conventional chemotherapy: a single-center, 10-year experience in Pakistan","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2019.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}